Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers March 26, 2017
Pharmacy Choice - News - U.S. Pharmaceutical Industry - March 26, 2017

Pharmacy News

 U.S. Pharmaceutical Industry
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

3/19/17 - Analyses Of PCSK9 Inhibitor Prescription Rejection Rates Demonstrate Significant Access Barriers For Appropriate Patients
Amgen today announced new data from two studies that showed that for appropriate patients in the U.S., the majority of prescription claims for PCSK9 inhibitors, such as Repatha , were initially rejected. The studies were presented at the American College of Cardiology 66 th Annual Scientific Session. In a retrospective study presented today as
3/19/17 - AstraZeneca to partner with respiratory drug company
AstraZeneca has entered into astrategic collaboration with Circassia Pharmaceuticals plc, a respiratory biopharmaceutical company, for the development and commercialisation ofTudorzaandDuaklirin the U.S.. AstraZeneca will receive a minority equity stake in Circassia. AstraZeneca will complete ongoing development activities and continue to...
3/19/17 - AstraZeneca's CVD-REAL Study Shows SGLT-2 Inhibitors Significantly Reduced Hospitalizations for Heart Failure and Death versus Other Type-2 Diabetes Medicines
AstraZeneca today announced results of the first large real-world evidence study of its kind evaluating the risk of hospitalization for heart failure and death from any cause in patients with type-2 diabetes receiving treatment with a newer class of diabetes medicines, SGLT-2 inhibitors. Bruce Cooper, MD, Vice President and Head of Global Medical A
3/19/17 - Chattanooga company among top clinical test facilities for new medicines [Chattanooga Times Free Press, Tenn.]
Dr. Krause retired from his own medical practice more than a decade ago, but the drug trial and testing business he started in 1996 ClinSearch has grown into Chattanooga's biggest clinical drug trial business. Krause has been a medical pioneer of sorts in Chattanooga since he came to town in 1977 as one of the city's first gastroenterologists a
3/19/17 - Findings from E. Burmeister Getz et al Has Provided New Information about Clinical Trials and Studies (Between-Batch Pharmacokinetic Variability...
By a News Reporter-Staff News Editor at Medical Letter on the CDC& FDA Investigators discuss new findings in Clinical Research- Clinical Trials and Studies. According to news reporting from Berkeley, California, by NewsRx journalists, research stated, "We previously demonstrated pharmacokinetic differences among manufacturing batches of a US Food
3/19/17 - Marathon offloads $89K muscular dystrophy drug after pricing uproar
CHICAGO Marathon Pharmaceuticals is ready for its turn as the poster child for high drug prices to be over. Following weeks of anger from patient advocates and members of Congress, the company announced Thursday morning that it plans to sell its $89,000- a-year Duchenne muscular dystrophy drug to PTC Therapeutics, a South Plainfield, N.J., compa
3/19/17 - MiMedx Announces The Addition Of Luis A. Aguilar To Its Board Of Directors
MiMedx Group, Inc., the leading regenerative medicine and biopharmaceutical company utilizing human placental tissue allografts and patent-protected processes to develop and market advanced products and therapies for multiple sectors of healthcare, announced today its Board of Directors has appointed Luis A. Aguilar, former Commissioner of the U.
3/18/17 - A front seat for the fight against AIDS [Star-News, Wilmington, N.C.]
March 18 Thirty years ago on March 19, 1987, to be exact the U.S. Food and Drug Administration approved the drug Zidovudine better known as azidothymidine, or AZT for treatment of HIV, AIDS and pre-AIDS illnesses. Wilmington resident Joseph Bigley knows this story firsthand. He supervised clinical trials on AZT as an employee of the famed
3/18/17 - Akari Therapeutics Announces R&D Day on April 24, 2017 [T-break Tech (Middle East)]
-Akari Therapeutics, an emerging growth, clinical-stage biopharmaceutical company, announced today that it will hold a Research and Development Day on April 24, 2017 in New York. Results from the pre-clinical development program targeting new disease opportunities for our lead compound Coversin, focusing on its unique dual leukotriene B4/ C5 activi
3/18/17 - Automated External Defibrillator Market Confident That Rise of Remote Healthcare Will Open New Growth Opportunities - MarketIntelReports
The report Global Automated External Defibrillator Market by Manufacturers, Regions, Type and Application, Forecast to 2022, available on MarketIntelReports, estimates that the prevalence of unhealthy lifestyles in countries like India will be a key future growth driver. Browse numerous Market Tables as well as Figures which are spread thro
3/18/17 - B vitamins may help reduce harm from air pollution [Philippines News Agency]
The study, led by Jia Zhong of Columbia University's Mailman School of Public Health, showed that B vitamins such as folic acid, vitamin B6 and vitamin B12 may play a critical role in reducing the impact of air pollution on a specific type of epigenetic modification called DNA methylation, which has been linked to cardiovascular disease and even ca
3/18/17 - Blood-Based Diagnostic Assay from Biodesix Measures Immunotherapy Biomarker PD-L1
By a News Reporter-Staff News Editor at Obesity, Fitness& Wellness Week New data from Biodesix evaluating an assay in development demonstrated the potential to measure circulating PD-L1 through mRNA in blood through multiplexed droplet digital? PCR detection. The assay uses proprietary RNA isolation methods consistent with Biodesix's...
3/18/17 - Business Group Makes Price Recommendations for Specialty Drugs [Sudan Tribune]
As specialty drugs become more prevalent, the costs associated with them must be lowered, according to a report from the National Business Group on Health. Their report, Policy Recommendations to Promote Sustainable, Affordable Pricing for Specialty Pharmaceuticals details how and why specialty drugs are increasing in price, and how those prices mi
3/18/17 - Cholesterol drug cuts heart risks, spurs new debate on cost Cholesterol drug cuts heart risks, spurs new debate on cost Cholesterol drug cuts heart risks, spurs new debate on cost A long-acting cholesterol medicine cut the risk of having a heart atta
A long-acting cholesterol medicine cut the risk of having a heart attack or some other serious problems by 15 to 20 percent in a big study that's likely to spur fresh debate about what drugs should cost. It costs more than $14,000 a year, and insurers have balked at paying without proof that it lowers heart risks, not just the cholesterol number.
3/18/17 - Cholesterol drug cuts heart risks, spurs new debate on cost
A long-acting cholesterol medicine cut the risk of having a heart attack or some other serious problems by 15 to 20 percent in a big study that's likely to spur fresh debate about what drugs should cost. It costs more than $14,000 a year, and insurers have balked at paying without proof that it lowers heart risks, not just the cholesterol number.
3/18/17 - Innovaccer Launches Payor Compare, a Free Tool to Help Care Teams Track and Monitor Medicare Advantage Plans
Innovaccer Inc., a Silicon Valley-Headquartered Healthcare Analytics company, announced the launch of Payor Compare, a free tool for care teams to track, monitor and analyze their performance in the Medicare Advantage Plan and overall trends. Payor Compare assimilates comprehensive historical and current data from over 33,000 Medicare Advantage P
3/18/17 - Renal Dialysis Equipment Market: Rising Global Population Of The Elderly Set To Hike Need For Dialysis Services - MarketIntelReports
The report Renal Dialysis Equipment- Medical Devices Pipeline Assessment, available on MarketIntelReports, estimates that Japan s aging society will turn into a key future growth driver. Browse 124 Market Tables as well as 6 Figures which are spread through 208 Pages and an in-depth TOC on the Renal Dialysis Equipment Market...
3/18/17 - Sarepta Therapeutics Announces Presentations at the 2017 MDA Scientific Conference [T-break Tech (Middle East)]
-Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company focused on the discovery and development of unique RNA-targeted therapeutics for the treatment of rare neuromuscular diseases, today provided an update to investors that it will present data from eteplirsen studies at the MDA Scientific Conference in Arlington, Virginia on...
3/18/17 - Sen. Murray Issues Statement on Selection of Gottlieb for FDA Commissioner
Patty Murray, D- Wash., ranking Democratic member of the Senate Health, Education, Labor and Pensions Committee, issued the following statement on March 11 on the selection of Scott Gottlieb to serve as commissioner of the Food and Drug Administration:. "Whether in the grocery store, the medicine cabinet, or the hospital, the health and safety of
3/18/17 - SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Egalet Corporation of Class Action Lawsuit and Upcoming Deadline - EGLT
NEW YORK, NY/ ACCESSWIRE/ March 17, 2017/ Pomerantz LLP announces that a class action lawsuit has been filed against Egalet Corporation and certain of its officers. The class action, filed in United States District Court, Eastern District of Pennsylvania, is on behalf of a class consisting of investors who purchased or otherwise acquired Egalet sec
3/18/17 - Take vitamin D supplements to cut autism traits in your newborn [Asian News International]
Washington D.C., Mar. 18: For mommies-to-be, taking vitamin D supplements during first trimester of pregnancy may prevent autism traits in their newborns, suggests a study conducted on mice. The University of Queensland researchers in Australia provided evidence of the crucial role that vitamin D plays in brain development,. "Our study used the mo
3/18/17 - Toshiba Medicals New Premium Cardiovascular Ultrasound Receives FDA Clearance [Tehran Times (Iran)]
The newly FDA- cleared system is the latest addition to the premium Aplio i-series ultrasound platform, helping to elevate cardiovascular ultrasound with excellent imaging clarity and definition. The Aplio i900 presents a real breakthrough in expanding the clinical utility of ultrasound, offering cardiologists a new tool for fast, safe and confiden
3/18/17 - Vertex Pharmaceuticals, Boston, Assigned Patent for DNA-PK Inhibitors
ALEXANDRIA, Va., March 18 Vertex Pharmaceuticals, Boston, has been assigned a patent developed by 17 co-inventors for DNA-PK inhibitors. The co-inventors are Paul S. Charifson, Framingham, Massachusetts, Kevin Michael Cottrell, Cambridge, Massachusetts, Hongbo Deng, Southborough, Massachusetts, John P. Duffy, Northborough, Massachusetts, Huai Gao
3/17/17 - "Dosing Preparation of Dabigatran Etexilate Or a Salt Thereof and a Preparation Method Thereof" in Patent Application Approval Process (USPTO...
By a News Reporter-Staff News Editor at Drug Week A patent application by the inventors SHENG, Xiaoxia; TANG, Yong, filed on October 8, 2015, was made available online on March 2, 2017, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application is assigned to SoliPharma LLC. Dabigatran etexila
3/17/17 - "Pharmaceutical Composition and Method for Treatment and Prevent of Hair Loss." in Patent Application Approval Process (USPTO 20170049675)
By a News Reporter-Staff News Editor at Drug Week A patent application by the inventor Momplaisir, Thierry, filed on August 4, 2016, was made available online on March 2, 2017, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application has not been assigned to a company or institution. The fol
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415